Novel kynureninase inhibitor KS79356 slows triple-negative breast cancer progression
Researchers at King Khalid University have identified a small molecule, KS79356, that potently blocks the growth, invasion, and migration of ...
Tag: targeted therapy for TNBC
Targeting MINK1 disrupts glucose metabolism to suppress triple-negative breast cancer
Triple-negative breast cancer, the most aggressive and hardest-to-treat form of breast cancer, may have a newly exposed weak point. A ...
Scientists discover molecule fueling one of breast cancer’s deadliest forms
Australian researchers have identified a molecular vulnerability that could help explain why triple-negative breast cancer so readily spreads through the ...
MARK2: The Key Protector of Mutant p53 in Aggressive Breast Cancer
In recent advancements in cancer biology, a groundbreaking study has shed new light on the intricate molecular mechanisms driving triple-negative ...
Experimental peptide therapy shows promise as a new target for treating metastatic breast cancer, finds UTHealth Houston researchers
A groundbreaking discovery in the fight against metastatic breast cancer has emerged from researchers at UTHealth Houston, revealing a promising ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!